News 145 results

In the News · Source: InsideHealthPolicy

April 8, 2021
The firm forms an industry group to challenge white bagging policies

In the News · Source: The Center for Biosimilars

March 30, 2021
Eva Temkin discusses the chances that biosimilars will be developed for orphan drugs

In the News · Source: Politico, Bloomberg Law, The Daily Docket, IP Magazine, Law.com, Law360, Bloomberg Law, Generics Bulletin, Pharmalife, Endpoints News and The Washington Post

March 29, 2021
Eva Temkin, former Acting Director for Policy at the FDA’s Office of Therapeutic Biologics and Biosimilars, joins the firm’s FDA & Life Sciences team in the Washington, D.C., office

In the News · Source: The Center for Biosimilars

March 29, 2021
Eva Temkin addresses the changing regulatory landscape and public perceptions of biosimilars